These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23482758)

  • 1. Naftopidil induces apoptosis in malignant mesothelioma cell lines independently of α1-adrenoceptor blocking.
    Masachika E; Kanno T; Nakano T; Gotoh A; Nishizaki T
    Anticancer Res; 2013 Mar; 33(3):887-94. PubMed ID: 23482758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naftopidil is useful for the treatment of malignant pleural mesothelioma.
    Mikami K; Nagaya H; Gotoh A; Kanno T; Tsuchiya A; Nakano T; Nishizaki T
    Pharmacology; 2014; 94(3-4):163-9. PubMed ID: 25301502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor action of α(1)-adrenoceptor blockers on human bladder, prostate and renal cancer cells.
    Gotoh A; Nagaya H; Kanno T; Nishizaki T
    Pharmacology; 2012; 90(5-6):242-6. PubMed ID: 23007551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of prostate cancer incidence by naftopidil, an α1 -adrenoceptor antagonist and transforming growth factor-β signaling inhibitor.
    Yamada D; Nishimatsu H; Kumano S; Hirano Y; Suzuki M; Fujimura T; Fukuhara H; Enomoto Y; Kume H; Homma Y
    Int J Urol; 2013 Dec; 20(12):1220-7. PubMed ID: 23600973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-[2-(2-Methoxyphenylamino)ethylamino]-3-(naphthalene-1-yloxy)propan-2-ol as a potential anticancer drug.
    Kanno T; Tanaka A; Shimizu T; Nakano T; Nishizaki T
    Pharmacology; 2013; 91(5-6):339-45. PubMed ID: 23817168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naftopidil, a selective {alpha}1-adrenoceptor antagonist, suppresses human prostate tumor growth by altering interactions between tumor cells and stroma.
    Hori Y; Ishii K; Kanda H; Iwamoto Y; Nishikawa K; Soga N; Kise H; Arima K; Sugimura Y
    Cancer Prev Res (Phila); 2011 Jan; 4(1):87-96. PubMed ID: 21205739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel naftopidil-related derivatives and their biological effects as alpha1-adrenoceptors antagonists and antiproliferative agents.
    Huang J; He F; Huang M; Liu X; Xiong Y; Huang Y; Zhu L; Yang Y; Xu X; Yuan M
    Eur J Med Chem; 2015; 96():83-91. PubMed ID: 25874333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
    Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
    Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipalmitoleoyl-phosphatidylethanolamine induces apoptosis of NCI-H28 malignant mesothelioma cells.
    Kaku Y; Tsuchiya A; Kanno T; Nakano T; Nishizaki T
    Anticancer Res; 2014 Apr; 34(4):1759-64. PubMed ID: 24692707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMP converted from intracellularly transported adenosine upregulates p53 expression to induce malignant pleural mesothelioma cell apoptosis.
    Nogi Y; Kanno T; Nakano T; Fujita Y; Tabata C; Fukuoka K; Gotoh A; Nishizaki T
    Cell Physiol Biochem; 2012; 30(1):61-74. PubMed ID: 22759956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.
    Cuellar DC; Rhee J; Kyprianou N
    Anticancer Res; 2002; 22(3):1673-9. PubMed ID: 12168853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change of expression levels of alpha1-adrenoceptor subtypes by administration of alpha1d-adrenoceptor-subtype-selective antagonist naftopidil in benign prostate hyperplasia patients.
    Kojima Y; Sasaki S; Shinoura H; Hayase M; Kubota Y; Hayashi Y; Tsujimoto G; Kohri K
    Prostate; 2007 Sep; 67(12):1285-92. PubMed ID: 17626248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors.
    Takei R; Ikegaki I; Shibata K; Tsujimoto G; Asano T
    Jpn J Pharmacol; 1999 Apr; 79(4):447-54. PubMed ID: 10361884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
    Nici L; Monfils B; Calabresi P
    Clin Cancer Res; 2004 Nov; 10(22):7655-61. PubMed ID: 15569998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia.
    Kojima Y; Sasaki S; Oda N; Koshimizu TA; Hayashi Y; Kiniwa M; Tsujimoto G; Kohri K
    Prostate; 2009 Oct; 69(14):1521-8. PubMed ID: 19544328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells.
    Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T
    J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol Induces Caspase-Independent Apoptosis of Malignant Pleural Mesothelioma Cells by Accumulating AIF in the Nucleus.
    Kanemura S; Tsuchiya A; Kanno T; Nakano T; Nishizaki T
    Cell Physiol Biochem; 2015; 36(3):1037-48. PubMed ID: 26112407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular alpha1-adrenoceptor subtype selectivity and alpha1-blocker-induced orthostatic hypotension.
    Take H; Shibata K; Awaji T; Hirasawa A; Ikegaki I; Asano T; Takada T; Tsujimoto G
    Jpn J Pharmacol; 1998 May; 77(1):61-70. PubMed ID: 9639061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of alpha1-adrenoceptor subtype mRNA as a predictor of the efficacy of subtype selective alpha1-adrenoceptor antagonists in the management of benign prostatic hyperplasia.
    Kojima Y; Sasaki S; Kubota Y; Hayase M; Hayashi Y; Shinoura H; Tsujimoto G; Kohri K
    J Urol; 2008 Mar; 179(3):1040-6. PubMed ID: 18206918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naftopidil, a selective alpha-1 adrenoceptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest.
    Kanda H; Ishii K; Ogura Y; Imamura T; Kanai M; Arima K; Sugimura Y
    Int J Cancer; 2008 Jan; 122(2):444-51. PubMed ID: 17918159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.